{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T00:53:31Z","timestamp":1795136011625,"version":"4.10.3"},"reference-count":209,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1038\/s41584-025-01267-0","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T07:16:38Z","timestamp":1750058198000},"page":"377-395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Immunometabolism in systemic lupus erythematosus"],"prefix":"10.1038","volume":"21","author":[{"given":"Eduardo","family":"Pati\u00f1o-Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2968-0815","authenticated-orcid":false,"given":"Mariana J.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"1267_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","volume":"17","author":"MRW Barber","year":"2021","unstructured":"Barber, M. R. W. et al. Global epidemiology of systemic lupus erythematosus. Nat. Rev. Rheumatol. 17, 515\u2013532 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1267_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41581-023-00797-8","volume":"20","author":"WG Ambler","year":"2024","unstructured":"Ambler, W. G. & Kaplan, M. J. Vascular damage in systemic lupus erythematosus. Nat. Rev. Nephrol. 20, 251\u2013265 (2024).","journal-title":"Nat. Rev. Nephrol."},{"key":"1267_CR3","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1073\/pnas.0337679100","volume":"100","author":"EC Baechler","year":"2003","unstructured":"Baechler, E. C. et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl Acad. Sci. USA 100, 2610\u20132615 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1267_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1146\/annurev-immunol-101921-042422","volume":"41","author":"S Caielli","year":"2023","unstructured":"Caielli, S., Wan, Z. & Pascual, V. Systemic lupus erythematosus pathogenesis: interferon and beyond. Annu. Rev. Immunol. 41, 533\u2013560 (2023).","journal-title":"Annu. Rev. Immunol."},{"key":"1267_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002084","volume":"21","author":"LP Blanco","year":"2023","unstructured":"Blanco, L. P. & Kaplan, M. J. Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases. PLoS Biol. 21, e3002084 (2023).","journal-title":"PLoS Biol."},{"key":"1267_CR6","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/ndt\/gfl635","volume":"22","author":"H Terawaki","year":"2007","unstructured":"Terawaki, H. et al. Elevated oxidative stress measured as albumin redox state in continuous ambulatory peritoneal dialysis patients correlates with small uraemic solutes. Nephrol. Dial. Transpl. 22, 968 (2007).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1267_CR7","doi-asserted-by":"publisher","first-page":"887228","DOI":"10.3389\/ftox.2022.887228","volume":"4","author":"R Leinardi","year":"2022","unstructured":"Leinardi, R., Longo Sanchez-Calero, C. & Huaux, F. Think beyond particle cytotoxicity: when self-cellular components released after immunogenic cell death explain chronic disease development. Front. Toxicol. 4, 887228 (2022).","journal-title":"Front. Toxicol."},{"key":"1267_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-024-01952-8","volume":"9","author":"Y Song","year":"2024","unstructured":"Song, Y., Li, J. & Wu, Y. Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. Signal. Transduct. Target. Ther. 9, 263 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1267_CR9","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jaci.2022.08.003","volume":"150","author":"M Doglio","year":"2022","unstructured":"Doglio, M. et al. New insights in systemic lupus erythematosus: from regulatory T cells to CAR-T-cell strategies. J. Allergy Clin. Immunol. 150, 1289\u20131301 (2022).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1267_CR10","doi-asserted-by":"publisher","first-page":"103326","DOI":"10.1016\/j.jaut.2024.103326","volume":"149","author":"QY Su","year":"2024","unstructured":"Su, Q. Y., Jiang, Z. Q., Song, X. Y. & Zhang, S. X. Regulatory B cells in autoimmune diseases: insights and therapeutic potential. J. Autoimmun. 149, 103326 (2024).","journal-title":"J. Autoimmun."},{"key":"1267_CR11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00018-022-04563-0","volume":"79","author":"S Yan","year":"2022","unstructured":"Yan, S., Kotschenreuther, K., Deng, S. & Kofler, D. M. Regulatory T cells in rheumatoid arthritis: functions, development, regulation, and therapeutic potential. Cell Mol. Life Sci. 79, 533 (2022).","journal-title":"Cell Mol. Life Sci."},{"key":"1267_CR12","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/ard-2022-223741","volume":"82","author":"MK Crow","year":"2023","unstructured":"Crow, M. K. Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Ann. Rheum. Dis. 82, 999\u20131014 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1267_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s41232-022-00198-7","volume":"42","author":"R Hachiya","year":"2022","unstructured":"Hachiya, R., Tanaka, M., Itoh, M. & Suganami, T. Molecular mechanism of crosstalk between immune and metabolic systems in metabolic syndrome. Inflamm. Regen. 42, 13 (2022).","journal-title":"Inflamm. Regen."},{"key":"1267_CR14","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.immuni.2020.08.012","volume":"53","author":"A Lercher","year":"2020","unstructured":"Lercher, A., Baazim, H. & Bergthaler, A. Systemic immunometabolism: challenges and opportunities. Immunity 53, 496\u2013509 (2020).","journal-title":"Immunity"},{"key":"1267_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41423-022-00840-x","volume":"19","author":"H Chi","year":"2022","unstructured":"Chi, H. Immunometabolism at the intersection of metabolic signaling, cell fate, and systems immunology. Cell Mol. Immunol. 19, 299\u2013302 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"1267_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10023-4","volume":"10","author":"N Jones","year":"2019","unstructured":"Jones, N. et al. Akt and STAT5 mediate naive human CD4+ T-cell early metabolic response to TCR stimulation. Nat. Commun. 10, 2042 (2019).","journal-title":"Nat. Commun."},{"key":"1267_CR17","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.4049\/jimmunol.1502581","volume":"197","author":"LE Padgett","year":"2016","unstructured":"Padgett, L. E. & Tse, H. M. NADPH oxidase-derived superoxide provides a third signal for CD4 T cell effector responses. J. Immunol. 197, 1733\u20131742 (2016).","journal-title":"J. Immunol."},{"key":"1267_CR18","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41577-021-00529-8","volume":"21","author":"K Voss","year":"2021","unstructured":"Voss, K. et al. A guide to interrogating immunometabolism. Nat. Rev. Immunol. 21, 637\u2013652 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1267_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg, O., Wind, F. & Negelein, E. The metabolism of tumors in the body. J. Gen. Physiol. 8, 519\u2013530 (1927).","journal-title":"J. Gen. Physiol."},{"key":"1267_CR20","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3389\/fimmu.2017.01636","volume":"8","author":"GA Robinson","year":"2017","unstructured":"Robinson, G. A., Waddington, K. E., Pineda-Torra, I. & Jury, E. C. Transcriptional regulation of T-cell lipid metabolism: implications for plasma membrane lipid rafts and T-cell function. Front. Immunol. 8, 1636 (2017).","journal-title":"Front. Immunol."},{"key":"1267_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.stemcr.2020.01.006","volume":"14","author":"C Liu","year":"2020","unstructured":"Liu, C. et al. HIF1\u0251 regulates early metabolic changes due to activation of innate immunity in nuclear reprogramming. Stem Cell Rep. 14, 192\u2013200 (2020).","journal-title":"Stem Cell Rep."},{"key":"1267_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1084\/jem.20040624","volume":"201","author":"SR Walmsley","year":"2005","unstructured":"Walmsley, S. R. et al. Hypoxia-induced neutrophil survival is mediated by HIF-1\u0251-dependent NF-\u03baB activity. J. Exp. Med. 201, 105\u2013115 (2005).","journal-title":"J. Exp. Med."},{"key":"1267_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","volume":"8","author":"V Panwar","year":"2023","unstructured":"Panwar, V. et al. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal. Transduct. Target. Ther. 8, 375 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1267_CR24","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cmet.2020.01.015","volume":"31","author":"A Gonzalez","year":"2020","unstructured":"Gonzalez, A., Hall, M. N., Lin, S. C. & Hardie, D. G. AMPK and TOR: the yin and yang of cellular nutrient sensing and growth control. Cell Metab. 31, 472\u2013492 (2020).","journal-title":"Cell Metab."},{"key":"1267_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","volume":"24","author":"V Lampropoulou","year":"2016","unstructured":"Lampropoulou, V. et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 24, 158\u2013166 (2016).","journal-title":"Cell Metab."},{"key":"1267_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114570","volume":"43","author":"LA Bourner","year":"2024","unstructured":"Bourner, L. A. et al. Endogenously produced itaconate negatively regulates innate-driven cytokine production and drives global ubiquitination in human macrophages. Cell Rep. 43, 114570 (2024).","journal-title":"Cell Rep."},{"key":"1267_CR27","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng, D., Liwinski, T. & Elinav, E. Interaction between microbiota and immunity in health and disease. Cell Res. 30, 492\u2013506 (2020).","journal-title":"Cell Res."},{"key":"1267_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1186892","volume":"14","author":"XF Liu","year":"2023","unstructured":"Liu, X. F. et al. Regulation of short-chain fatty acids in the immune system. Front. Immunol. 14, 1186892 (2023).","journal-title":"Front. Immunol."},{"key":"1267_CR29","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.3390\/cancers13164054","volume":"13","author":"Y Chen","year":"2021","unstructured":"Chen, Y. & Chen, Y. X. Microbiota-associated metabolites and related immunoregulation in colorectal cancer. Cancers 13, 4054 (2021).","journal-title":"Cancers"},{"key":"1267_CR30","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","volume":"341","author":"PM Smith","year":"2013","unstructured":"Smith, P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569\u2013573 (2013).","journal-title":"Science"},{"key":"1267_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep12689","volume":"5","author":"TD Hubbard","year":"2015","unstructured":"Hubbard, T. D. et al. Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles. Sci. Rep. 5, 12689 (2015).","journal-title":"Sci. Rep."},{"key":"1267_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.immuni.2014.05.016","volume":"41","author":"S Kawamoto","year":"2014","unstructured":"Kawamoto, S. et al. Foxp3+ T cells regulate immunoglobulin a selection and facilitate diversification of bacterial species responsible for immune homeostasis. Immunity 41, 152\u2013165 (2014).","journal-title":"Immunity"},{"key":"1267_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202300211","volume":"8","author":"M Geiger","year":"2024","unstructured":"Geiger, M. et al. Epigenetic network in immunometabolic disease. Adv. Biol. 8, e2300211 (2024).","journal-title":"Adv. Biol."},{"key":"1267_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","volume":"172","author":"S Bekkering","year":"2018","unstructured":"Bekkering, S. et al. Metabolic induction of trained immunity through the mevalonate pathway. Cell 172, 135\u2013146 e139 (2018).","journal-title":"Cell"},{"key":"1267_CR35","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/art.42724","volume":"76","author":"EN Montano","year":"2024","unstructured":"Montano, E. N. et al. \u0251-ketoglutarate-dependent KDM6 histone demethylases and interferon-stimulated gene expression in lupus. Arthritis Rheumatol. 76, 396\u2013410 (2024).","journal-title":"Arthritis Rheumatol."},{"key":"1267_CR36","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s12276-023-01020-1","volume":"55","author":"X Xu","year":"2023","unstructured":"Xu, X. et al. Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. Exp. Mol. Med. 55, 1357\u20131370 (2023).","journal-title":"Exp. Mol. Med."},{"key":"1267_CR37","doi-asserted-by":"publisher","first-page":"112149","DOI":"10.1016\/j.intimp.2024.112149","volume":"134","author":"S Cao","year":"2024","unstructured":"Cao, S., Jiang, J., Yin, H., Wang, L. & Lu, Q. Abnormal energy metabolism in the pathogenesis of systemic lupus erythematosus. Int. Immunopharmacol. 134, 112149 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"1267_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","volume":"9","author":"Y Zong","year":"2024","unstructured":"Zong, Y. et al. Mitochondrial dysfunction: mechanisms and advances in therapy. Signal. Transduct. Target. Ther. 9, 124 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1267_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132499","volume":"10","author":"W Wu","year":"2015","unstructured":"Wu, W. et al. PINK1-parkin-mediated mitophagy protects mitochondrial integrity and prevents metabolic stress-induced endothelial injury. PLoS One 10, e0132499 (2015).","journal-title":"PLoS One"},{"key":"1267_CR40","doi-asserted-by":"publisher","first-page":"eaav5928","DOI":"10.1126\/scitranslmed.aav5928","volume":"13","author":"I Melki","year":"2021","unstructured":"Melki, I. et al. Platelets release mitochondrial antigens in systemic lupus erythematosus. Sci. Transl. Med. 13, eaav5928 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1267_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159384","volume":"11","author":"AA Bengtsson","year":"2016","unstructured":"Bengtsson, A. A. et al. Metabolic profiling of systemic lupus erythematosus and comparison with primary Sjogren\u2019s syndrome and systemic sclerosis. PLoS One 11, e0159384 (2016).","journal-title":"PLoS One"},{"key":"1267_CR42","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/S0021-9258(17)35926-4","volume":"261","author":"S Bannai","year":"1986","unstructured":"Bannai, S. Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J. Biol. Chem. 261, 2256\u20132263 (1986).","journal-title":"J. Biol. Chem."},{"key":"1267_CR43","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/ard-2023-225349","volume":"83","author":"LM Carter","year":"2024","unstructured":"Carter, L. M. et al. Blood RNA-sequencing across the continuum of ANA-positive autoimmunity reveals insights into initiating immunopathology. Ann. Rheum. Dis. 83, 1322\u20131334 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"1267_CR44","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1136\/annrheumdis-2017-212935","volume":"77","author":"PC Grayson","year":"2018","unstructured":"Grayson, P. C. et al. Metabolic pathways and immunometabolism in rare kidney diseases. Ann. Rheum. Dis. 77, 1226\u20131233 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"1267_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93034-w","volume":"11","author":"KM Kingsmore","year":"2021","unstructured":"Kingsmore, K. M. et al. Altered expression of genes controlling metabolism characterizes the tissue response to immune injury in lupus. Sci. Rep. 11, 14789 (2021).","journal-title":"Sci. Rep."},{"key":"1267_CR46","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s11306-015-0772-0","volume":"11","author":"A Perl","year":"2015","unstructured":"Perl, A. et al. Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin. Metabolomics 11, 1157\u20131174 (2015).","journal-title":"Metabolomics"},{"key":"1267_CR47","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.122312","volume":"5","author":"WA Haynes","year":"2020","unstructured":"Haynes, W. A. et al. Integrated, multicohort analysis reveals unified signature of systemic lupus erythematosus. JCI Insight 5, e122312 (2020).","journal-title":"JCI Insight"},{"key":"1267_CR48","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1093\/rheumatology\/kead646","volume":"63","author":"EC Jury","year":"2024","unstructured":"Jury, E. C. et al. Systemic lupus erythematosus patients have unique changes in serum metabolic profiles across age associated with cardiometabolic risk. Rheumatology 63, 2741\u20132753 (2024).","journal-title":"Rheumatology"},{"key":"1267_CR49","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1136\/annrheumdis-2018-214379","volume":"78","author":"NI Panousis","year":"2019","unstructured":"Panousis, N. I. et al. Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity. Ann. Rheum. Dis. 78, 1079\u20131089 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"1267_CR50","doi-asserted-by":"publisher","first-page":"108602","DOI":"10.1016\/j.clim.2020.108602","volume":"221","author":"DJ Perry","year":"2020","unstructured":"Perry, D. J., Titov, A. A., Sobel, E. S., Brusko, T. M. & Morel, L. Immunophenotyping reveals distinct subgroups of lupus patients based on their activated T cell subsets. Clin. Immunol. 221, 108602 (2020).","journal-title":"Clin. Immunol."},{"key":"1267_CR51","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1136\/annrheumdis-2021-221464","volume":"81","author":"Y Takeshima","year":"2022","unstructured":"Takeshima, Y. et al. Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus. Ann. Rheum. Dis. 81, 845\u2013853 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"1267_CR52","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/rheumatology\/keac338","volume":"62","author":"Y Iwasaki","year":"2023","unstructured":"Iwasaki, Y. et al. Combined plasma metabolomic and transcriptomic analysis identify histidine as a biomarker and potential contributor in SLE pathogenesis. Rheumatology 62, 905\u2013913 (2023).","journal-title":"Rheumatology"},{"key":"1267_CR53","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1021\/acs.jproteome.0c00619","volume":"20","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Time course of metabolic alterations associated with the progression of systemic lupus erythematosus in MRL\/lpr mice based on GC\/MS. J. Proteome Res. 20, 1243\u20131251 (2021).","journal-title":"J. Proteome Res."},{"key":"1267_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32569-6","volume":"13","author":"KA Owen","year":"2023","unstructured":"Owen, K. A. et al. Molecular pathways identified from single nucleotide polymorphisms demonstrate mechanistic differences in systemic lupus erythematosus patients of Asian and European ancestry. Sci. Rep. 13, 5339 (2023).","journal-title":"Sci. Rep."},{"key":"1267_CR55","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/ijms21010287","volume":"21","author":"L Injarabian","year":"2019","unstructured":"Injarabian, L., Devin, A., Ransac, S. & Marteyn, B. S. Neutrophil metabolic shift during their lifecycle: impact on their survival and activation. Int. J. Mol. Sci. 21, 287 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1267_CR56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/jcp.1040910110","volume":"91","author":"LA Boxer","year":"1977","unstructured":"Boxer, L. A., Baehner, R. L. & Davis, J. The effect of 2-deoxyglucose on guinea pig polymorphonuclear leukocyte phagocytosis. J. Cell Physiol. 91, 89\u2013102 (1977).","journal-title":"J. Cell Physiol."},{"key":"1267_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.165542","volume":"1865","author":"D Awasthi","year":"2019","unstructured":"Awasthi, D. et al. Glycolysis dependent lactate formation in neutrophils: a metabolic link between NOX-dependent and independent NETosis. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 165542 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"1267_CR58","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/cdd.2009.96","volume":"16","author":"S Yousefi","year":"2009","unstructured":"Yousefi, S., Mihalache, C., Kozlowski, E., Schmid, I. & Simon, H. U. Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ. 16, 1438\u20131444 (2009).","journal-title":"Cell Death Differ."},{"key":"1267_CR59","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/BOR.0000000000001054","volume":"37","author":"N Hanata","year":"2025","unstructured":"Hanata, N. & Kaplan, M. J. The role of neutrophil extracellular traps in inflammatory rheumatic diseases. Curr. Opin. Rheumatol. 37, 64\u201371 (2025).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1267_CR60","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99276","volume":"3","author":"PM Carlucci","year":"2018","unstructured":"Carlucci, P. M. et al. Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus. JCI Insight 3, e99276 (2018).","journal-title":"JCI Insight"},{"key":"1267_CR61","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/BOR.0000000000000413","volume":"29","author":"YL Lightfoot","year":"2017","unstructured":"Lightfoot, Y. L., Blanco, L. P. & Kaplan, M. J. Metabolic abnormalities and oxidative stress in lupus. Curr. Opin. Rheumatol. 29, 442\u2013449 (2017).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1267_CR62","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1084\/jem.20151876","volume":"213","author":"S Caielli","year":"2016","unstructured":"Caielli, S. et al. Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus. J. Exp. Med. 213, 697\u2013713 (2016).","journal-title":"J. Exp. Med."},{"key":"1267_CR63","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00281-013-0375-7","volume":"35","author":"C Carmona-Rivera","year":"2013","unstructured":"Carmona-Rivera, C. & Kaplan, M. J. Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity. Semin. Immunopathol. 35, 455\u2013463 (2013).","journal-title":"Semin. Immunopathol."},{"key":"1267_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2025.103399","volume":"152","author":"H Xu","year":"2025","unstructured":"Xu, H. et al. Aberrant expansion of CD177+ neutrophils promotes endothelial dysfunction in systemic lupus erythematosus via neutrophil extracellular traps. J. Autoimmun. 152, 103399 (2025).","journal-title":"J. Autoimmun."},{"key":"1267_CR65","doi-asserted-by":"publisher","first-page":"73ra20","DOI":"10.1126\/scitranslmed.3001201","volume":"3","author":"GS Garcia-Romo","year":"2011","unstructured":"Garcia-Romo, G. S. et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra20 (2011).","journal-title":"Sci. Transl. Med."},{"key":"1267_CR66","doi-asserted-by":"publisher","first-page":"9813","DOI":"10.1073\/pnas.0909927107","volume":"107","author":"A Hakkim","year":"2010","unstructured":"Hakkim, A. et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl Acad. Sci. USA 107, 9813\u20139818 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1267_CR67","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4049\/jimmunol.1100450","volume":"187","author":"E Villanueva","year":"2011","unstructured":"Villanueva, E. et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J. Immunol. 187, 538\u2013552 (2011).","journal-title":"J. Immunol."},{"key":"1267_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1150","volume":"13","author":"KR Martin","year":"2023","unstructured":"Martin, K. R. et al. CD98 defines a metabolically flexible, proinflammatory subset of low-density neutrophils in systemic lupus erythematosus. Clin. Transl. Med. 13, e1150 (2023).","journal-title":"Clin. Transl. Med."},{"key":"1267_CR69","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1083\/jcb.200806072","volume":"184","author":"Y Wang","year":"2009","unstructured":"Wang, Y. et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J. Cell Biol. 184, 205\u2013213 (2009).","journal-title":"J. Cell Biol."},{"key":"1267_CR70","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1083\/jcb.200606027","volume":"176","author":"TA Fuchs","year":"2007","unstructured":"Fuchs, T. A. et al. Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176, 231\u2013241 (2007).","journal-title":"J. Cell Biol."},{"key":"1267_CR71","doi-asserted-by":"publisher","first-page":"eaax7942","DOI":"10.1126\/scisignal.aax7942","volume":"14","author":"F Apel","year":"2021","unstructured":"Apel, F. et al. The cytosolic DNA sensor cGAS recognizes neutrophil extracellular traps. Sci. Signal. 14, eaax7942 (2021).","journal-title":"Sci. Signal."},{"key":"1267_CR72","doi-asserted-by":"publisher","DOI":"10.1172\/JCI169893","volume":"134","author":"A Tambralli","year":"2024","unstructured":"Tambralli, A. et al. Neutrophil glucose flux as a therapeutic target in antiphospholipid syndrome. J. Clin. Invest. 134, e169893 (2024).","journal-title":"J. Clin. Invest."},{"key":"1267_CR73","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nm.4027","volume":"22","author":"C Lood","year":"2016","unstructured":"Lood, C. et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat. Med. 22, 146\u2013153 (2016).","journal-title":"Nat. Med."},{"key":"1267_CR74","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1002\/art.41796","volume":"73","author":"LP Blanco","year":"2021","unstructured":"Blanco, L. P. et al. RNA externalized by neutrophil extracellular traps promotes inflammatory pathways in endothelial cells. Arthritis Rheumatol. 73, 2282\u20132292 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"1267_CR75","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/art.43062","volume":"77","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. Role of STING deficiency in amelioration of mouse models of lupus and atherosclerosis. Arthritis Rheumatol. 77, 547\u2013559 (2025).","journal-title":"Arthritis Rheumatol"},{"key":"1267_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36522-z","volume":"14","author":"N Miao","year":"2023","unstructured":"Miao, N. et al. Oxidized mitochondrial DNA induces gasdermin D oligomerization in systemic lupus erythematosus. Nat. Commun. 14, 872 (2023).","journal-title":"Nat. Commun."},{"key":"1267_CR77","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.immuni.2013.08.004","volume":"39","author":"N Gehrke","year":"2013","unstructured":"Gehrke, N. et al. Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing. Immunity 39, 482\u2013495 (2013).","journal-title":"Immunity"},{"key":"1267_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40900-3","volume":"9","author":"Y Becker","year":"2019","unstructured":"Becker, Y. et al. Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations. Sci. Rep. 9, 4530 (2019).","journal-title":"Sci. Rep."},{"key":"1267_CR79","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1126\/science.aav4011","volume":"366","author":"RG Jeonghan Kim","year":"2019","unstructured":"Jeonghan Kim, R. G. et al. VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease. Science 366, 1531\u20131536 (2019).","journal-title":"Science"},{"key":"1267_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33711-0","volume":"13","author":"S Noreng","year":"2022","unstructured":"Noreng, S. et al. Structure of the core human NADPH oxidase NOX2. Nat. Commun. 13, 6079 (2022).","journal-title":"Nat. Commun."},{"key":"1267_CR81","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/annrheumdis-2019-215820","volume":"79","author":"P Linge","year":"2020","unstructured":"Linge, P. et al. NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus. Ann. Rheum. Dis. 79, 254\u2013261 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"1267_CR82","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/hmg\/ddt532","volume":"23","author":"X Kim-Howard","year":"2014","unstructured":"Kim-Howard, X. et al. Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations. Hum. Mol. Genet. 23, 1656\u20131668 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"1267_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002341","volume":"7","author":"DS Cunninghame Graham","year":"2011","unstructured":"Cunninghame Graham, D. S. et al. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet. 7, e1002341 (2011).","journal-title":"PLoS Genet."},{"key":"1267_CR84","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92920","volume":"2","author":"D Kienhofer","year":"2017","unstructured":"Kienhofer, D. et al. Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps. JCI Insight 2, e92920 (2017).","journal-title":"JCI Insight"},{"key":"1267_CR85","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/art.40141","volume":"69","author":"CO Jacob","year":"2017","unstructured":"Jacob, C. O. et al. Haploinsufficiency of NADPH oxidase subunit neutrophil cytosolic factor 2 is sufficient to accelerate full-blown lupus in NZM 2328 mice. Arthritis Rheumatol. 69, 1647\u20131660 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"1267_CR86","doi-asserted-by":"publisher","first-page":"12595","DOI":"10.1074\/jbc.M115.639021","volume":"290","author":"DL Armstrong","year":"2015","unstructured":"Armstrong, D. L., Eisenstein, M., Zidovetzki, R. & Jacob, C. O. Systemic lupus erythematosus-associated neutrophil cytosolic factor 2 mutation affects the structure of NADPH oxidase complex. J. Biol. Chem. 290, 12595\u201312602 (2015).","journal-title":"J. Biol. Chem."},{"key":"1267_CR87","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41423-021-00791-9","volume":"19","author":"SK Wculek","year":"2022","unstructured":"Wculek, S. K., Dunphy, G., Heras-Murillo, I., Mastrangelo, A. & Sancho, D. Metabolism of tissue macrophages in homeostasis and pathology. Cell Mol. Immunol. 19, 384\u2013408 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"1267_CR88","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/imr.13318","volume":"323","author":"SM O\u2019Carroll","year":"2024","unstructured":"O\u2019Carroll, S. M., Henkel, F. D. R. & O\u2019Neill, L. A. J. Metabolic regulation of type I interferon production. Immunol. Rev. 323, 276\u2013287 (2024).","journal-title":"Immunol. Rev."},{"key":"1267_CR89","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000519305","volume":"14","author":"VD Cuevas","year":"2022","unstructured":"Cuevas, V. D. et al. The gene signature of activated M-CSF-primed human monocyte-derived macrophages is IL-10-dependent. J. Innate Immun. 14, 243\u2013256 (2022).","journal-title":"J. Innate Immun."},{"key":"1267_CR90","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.159751","volume":"7","author":"N Richoz","year":"2022","unstructured":"Richoz, N. et al. Distinct pathogenic roles for resident and monocyte-derived macrophages in lupus nephritis. JCI Insight 7, e159751 (2022).","journal-title":"JCI Insight"},{"key":"1267_CR91","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1073\/pnas.0914902107","volume":"107","author":"A Triantafyllopoulou","year":"2010","unstructured":"Triantafyllopoulou, A. et al. Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc. Natl Acad. Sci. USA 107, 3012\u20133017 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1267_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1477708","volume":"15","author":"Y Cheng","year":"2024","unstructured":"Cheng, Y. et al. Roles of macrophages in lupus nephritis. Front. Pharmacol. 15, 1477708 (2024).","journal-title":"Front. Pharmacol."},{"key":"1267_CR93","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1073\/pnas.1117736109","volume":"109","author":"B Ravishankar","year":"2012","unstructured":"Ravishankar, B. et al. Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase. Proc. Natl Acad. Sci. USA 109, 3909\u20133914 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1267_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.680068","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Pyruvate kinase M2 contributes to TLR-mediated inflammation and autoimmunity by promoting Pyk2 activation. Front. Immunol. 12, 680068 (2021).","journal-title":"Front. Immunol."},{"key":"1267_CR95","doi-asserted-by":"publisher","first-page":"795","DOI":"10.4049\/jimmunol.2300758","volume":"213","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. Mitochondrial DNA programs lactylation of cGAS to induce IFN responses in patients with systemic lupus erythematosus. J. Immunol. 213, 795\u2013807 (2024).","journal-title":"J. Immunol."},{"key":"1267_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2019.06.009","volume":"207","author":"C Ma","year":"2019","unstructured":"Ma, C., Xia, Y., Yang, Q. & Zhao, Y. The contribution of macrophages to systemic lupus erythematosus. Clin. Immunol. 207, 1\u20139 (2019).","journal-title":"Clin. Immunol."},{"key":"1267_CR97","doi-asserted-by":"publisher","first-page":"10774","DOI":"10.1073\/pnas.1504276112","volume":"112","author":"B Ravishankar","year":"2015","unstructured":"Ravishankar, B. et al. The amino acid sensor GCN2 inhibits inflammatory responses to apoptotic cells promoting tolerance and suppressing systemic autoimmunity. Proc. Natl Acad. Sci. USA 112, 10774\u201310779 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1267_CR98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2100295118","volume":"118","author":"T Kobayashi","year":"2021","unstructured":"Kobayashi, T. et al. SLC15A4 mediates M1-prone metabolic shifts in macrophages and guards immune cells from metabolic stress. Proc. Natl Acad. Sci. USA 118, e2100295118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1267_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112916","volume":"42","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. SLC15A4 controls endolysosomal TLR7-9 responses by recruiting the innate immune adaptor TASL. Cell Rep. 42, 112916 (2023).","journal-title":"Cell Rep."},{"key":"1267_CR100","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/ng.472","volume":"41","author":"JW Han","year":"2009","unstructured":"Han, J. W. et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41, 1234\u20131237 (2009).","journal-title":"Nat. Genet."},{"key":"1267_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms16021","volume":"8","author":"CD Langefeld","year":"2017","unstructured":"Langefeld, C. D. et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat. Commun. 8, 16021 (2017).","journal-title":"Nat. Commun."},{"key":"1267_CR102","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/ejhg.2012.277","volume":"21","author":"C Wang","year":"2013","unstructured":"Wang, C. et al. Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations. Eur. J. Hum. Genet. 21, 994\u2013999 (2013).","journal-title":"Eur. J. Hum. Genet."},{"key":"1267_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244439","volume":"16","author":"A Katewa","year":"2021","unstructured":"Katewa, A. et al. The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models. PLoS One 16, e0244439 (2021).","journal-title":"PLoS One"},{"key":"1267_CR104","doi-asserted-by":"publisher","first-page":"936967","DOI":"10.3389\/fimmu.2022.936967","volume":"13","author":"C Liu","year":"2022","unstructured":"Liu, C., Liu, C. & Fu, R. Research progress on the role of PKM2 in the immune response. Front. Immunol. 13, 936967 (2022).","journal-title":"Front. Immunol."},{"key":"1267_CR105","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.kint.2023.03.030","volume":"104","author":"EJ Yoo","year":"2023","unstructured":"Yoo, E. J. et al. Macrophage transcription factor TonEBP promotes systemic lupus erythematosus and kidney injury via damage-induced signaling pathways. Kidney Int. 104, 163\u2013180 (2023).","journal-title":"Kidney Int."},{"key":"1267_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24609-4","volume":"12","author":"T Ban","year":"2021","unstructured":"Ban, T. et al. Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease. Nat. Commun. 12, 4379 (2021).","journal-title":"Nat. Commun."},{"key":"1267_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110285","volume":"265","author":"JH Lai","year":"2024","unstructured":"Lai, J. H. et al. USP18 induction regulates immunometabolism to attenuate M1 signal-polarized macrophages and enhance IL-4-polarized macrophages in systemic lupus erythematosus. Clin. Immunol. 265, 110285 (2024).","journal-title":"Clin. Immunol."},{"key":"1267_CR108","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq9301","volume":"11","author":"J Wu","year":"2025","unstructured":"Wu, J. et al. Mitochondrial fatty acid oxidation regulates monocytic type I interferon signaling via histone acetylation. Sci. Adv. 11, eadq9301 (2025).","journal-title":"Sci. Adv."},{"key":"1267_CR109","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1016\/j.cell.2021.07.021","volume":"184","author":"S Caielli","year":"2021","unstructured":"Caielli, S. et al. Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE. Cell 184, 4464\u20134479.e19 (2021).","journal-title":"Cell"},{"key":"1267_CR110","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","volume":"19","author":"G Jego","year":"2003","unstructured":"Jego, G. et al. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19, 225\u2013234 (2003).","journal-title":"Immunity"},{"key":"1267_CR111","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/JLB.3HI0220-130","volume":"109","author":"HJ Hurley","year":"2021","unstructured":"Hurley, H. J. et al. Frontline Science: AMPK regulates metabolic reprogramming necessary for interferon production in human plasmacytoid dendritic cells. J. Leukoc. Biol. 109, 299\u2013308 (2021).","journal-title":"J. Leukoc. Biol."},{"key":"1267_CR112","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.immuni.2016.06.006","volume":"44","author":"D Wu","year":"2016","unstructured":"Wu, D. et al. Type 1 interferons induce changes in core metabolism that are critical for immune function. Immunity 44, 1325\u20131336 (2016).","journal-title":"Immunity"},{"key":"1267_CR113","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153619","volume":"132","author":"Y Meng","year":"2022","unstructured":"Meng, Y. et al. The NCF1 variant p.R90H aggravates autoimmunity by facilitating the activation of plasmacytoid dendritic cells. J. Clin. Invest. 132, e153619 (2022).","journal-title":"J. Clin. Invest."},{"key":"1267_CR114","doi-asserted-by":"publisher","first-page":"E6195","DOI":"10.1073\/pnas.1507052112","volume":"112","author":"T Celhar","year":"2015","unstructured":"Celhar, T. et al. RNA sensing by conventional dendritic cells is central to the development of lupus nephritis. Proc. Natl Acad. Sci. USA 112, E6195\u2013E6204 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1267_CR115","doi-asserted-by":"publisher","first-page":"1601079","DOI":"10.1155\/2018\/1601079","volume":"2018","author":"MH Lee","year":"2018","unstructured":"Lee, M. H., Chakhtoura, M., Sriram, U., Caricchio, R. & Gallucci, S. Conventional DCs from male and female lupus-prone B6.NZM Sle1\/Sle2\/Sle3 mice express an IFN signature and have a higher immunometabolism that are enhanced by estrogen. J. Immunol. Res. 2018, 1601079 (2018).","journal-title":"J. Immunol. Res."},{"key":"1267_CR116","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3389\/fimmu.2019.00739","volume":"10","author":"W Hoepel","year":"2019","unstructured":"Hoepel, W. et al. Fc\u03b3R-TLR cross-talk enhances TNF production by human monocyte-derived DCs via IRF5-dependent gene transcription and glycolytic reprogramming. Front. Immunol. 10, 739 (2019).","journal-title":"Front. Immunol."},{"key":"1267_CR117","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/art.38955","volume":"67","author":"T Schmidt","year":"2015","unstructured":"Schmidt, T. et al. Function of the Th17\/interleukin-17A immune response in murine lupus nephritis. Arthritis Rheumatol. 67, 475\u2013487 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"1267_CR118","first-page":"65","volume":"10","author":"Y Yuliasih","year":"2019","unstructured":"Yuliasih, Y., Rahmawati, L. D. & Putri, R. M. Th17\/Treg ratio and disease activity in systemic lupus erythematosus. Caspian J. Intern. Med. 10, 65\u201372 (2019).","journal-title":"Caspian J. Intern. Med."},{"key":"1267_CR119","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4927530","volume":"2016","author":"KR Sigdel","year":"2016","unstructured":"Sigdel, K. R. et al. Serum Cytokines Th1, Th2, and Th17 expression profiling in active lupus nephritis-IV: from a southern Chinese Han population. Mediators Inflamm. 2016, 4927530 (2016).","journal-title":"Mediators Inflamm."},{"key":"1267_CR120","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/art.23556","volume":"58","author":"RK Venigalla","year":"2008","unstructured":"Venigalla, R. K. et al. Reduced CD4+,CD25\u2212 T cell sensitivity to the suppressive function of CD4+,CD25high,CD127\u2212\/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum. 58, 2120\u20132130 (2008).","journal-title":"Arthritis Rheum."},{"key":"1267_CR121","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H","volume":"46","author":"P Gergely Jr.","year":"2002","unstructured":"Gergely, P. Jr. et al. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum. 46, 175\u2013190 (2002).","journal-title":"Arthritis Rheum."},{"key":"1267_CR122","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.4049\/jimmunol.169.2.1092","volume":"169","author":"P Gergely Jr.","year":"2002","unstructured":"Gergely, P. Jr. et al. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus. J. Immunol. 169, 1092\u20131101 (2002).","journal-title":"J. Immunol."},{"key":"1267_CR123","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.4049\/jimmunol.173.6.3676","volume":"173","author":"G Nagy","year":"2004","unstructured":"Nagy, G., Barcza, M., Gonchoroff, N., Phillips, P. E. & Perl, A. Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells. J. Immunol. 173, 3676\u20133683 (2004).","journal-title":"J. Immunol."},{"key":"1267_CR124","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.4049\/jimmunol.0803600","volume":"182","author":"DR Fernandez","year":"2009","unstructured":"Fernandez, D. R. et al. Activation of mammalian target of rapamycin controls the loss of TCR\u03b6 in lupus T cells through HRES-1\/Rab4-regulated lysosomal degradation. J. Immunol. 182, 2063\u20132073 (2009).","journal-title":"J. Immunol."},{"key":"1267_CR125","doi-asserted-by":"publisher","first-page":"ra115","DOI":"10.1126\/scisignal.aaf1933","volume":"9","author":"IA Buskiewicz","year":"2016","unstructured":"Buskiewicz, I. A. et al. Reactive oxygen species induce virus-independent MAVS oligomerization in systemic lupus erythematosus. Sci. Signal. 9, ra115 (2016).","journal-title":"Sci. Signal."},{"key":"1267_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-014-0303-1","volume":"12","author":"YJ Su","year":"2014","unstructured":"Su, Y. J. et al. Investigation of the caspase-dependent mitochondrial apoptotic pathway in mononuclear cells of patients with systemic lupus erythematosus. J. Transl. Med. 12, 303 (2014).","journal-title":"J. Transl. Med."},{"key":"1267_CR127","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3389\/fimmu.2019.00833","volume":"10","author":"W Li","year":"2019","unstructured":"Li, W. et al. Targeting T cell activation and lupus autoimmune phenotypes by inhibiting glucose transporters. Front. Immunol. 10, 833 (2019).","journal-title":"Front. Immunol."},{"key":"1267_CR128","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4049\/jimmunol.1501537","volume":"196","author":"Y Yin","year":"2016","unstructured":"Yin, Y. et al. Glucose oxidation is critical for CD4+ T cell activation in a mouse model of systemic lupus erythematosus. J. Immunol. 196, 80\u201390 (2016).","journal-title":"J. Immunol."},{"key":"1267_CR129","first-page":"274ra218","volume":"7","author":"S-CC Yiming Yin","year":"2015","unstructured":"Yiming Yin, S.-C. C. et al. Normalization of CD4+ T cell metabolism reverses lupus. Sci. Transl. Med. 7, 274ra218 (2015).","journal-title":"Sci. Transl. Med."},{"key":"1267_CR130","doi-asserted-by":"publisher","first-page":"9288","DOI":"10.1073\/pnas.1805717115","volume":"115","author":"M Kono","year":"2018","unstructured":"Kono, M. et al. Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation. Proc. Natl Acad. Sci. USA 115, 9288\u20139293 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1267_CR131","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1016\/j.jfma.2022.05.003","volume":"121","author":"HJ Liao","year":"2022","unstructured":"Liao, H. J., Chu, C. L., Wang, S. C., Lee, H. Y. & Wu, C. S. Increased HIF-1\u0251 expression in T cells and associated with enhanced Th17 pathway in systemic lupus erythematosus. J. Formos. Med. Assoc. 121, 2446\u20132456 (2022).","journal-title":"J. Formos. Med. Assoc."},{"key":"1267_CR132","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/art.40785","volume":"71","author":"T Koga","year":"2019","unstructured":"Koga, T. et al. Promotion of calcium\/calmodulin-dependent protein kinase 4 by GLUT1-dependent glycolysis in systemic lupus erythematosus. Arthritis Rheumatol. 71, 766\u2013772 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"1267_CR133","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1172\/JCI22854","volume":"115","author":"YT Juang","year":"2005","unstructured":"Juang, Y. T. et al. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J. Clin. Invest. 115, 996\u20131005 (2005).","journal-title":"J. Clin. Invest."},{"key":"1267_CR134","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1172\/JCI110579","volume":"69","author":"J Alcocer-Varela","year":"1982","unstructured":"Alcocer-Varela, J. & Alarcon-Segovia, D. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J. Clin. Invest. 69, 1388\u20131392 (1982).","journal-title":"J. Clin. Invest."},{"key":"1267_CR135","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1172\/JCI73411","volume":"124","author":"T Koga","year":"2014","unstructured":"Koga, T. et al. CaMK4-dependent activation of AKT\/mTOR and CREM-\u0251 underlies autoimmunity-associated Th17 imbalance. J. Clin. Invest. 124, 2234\u20132245 (2014).","journal-title":"J. Clin. Invest."},{"key":"1267_CR136","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","volume":"16","author":"A Sharabi","year":"2020","unstructured":"Sharabi, A. & Tsokos, G. C. T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy. Nat. Rev. Rheumatol. 16, 100\u2013112 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1267_CR137","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.4049\/jimmunol.1301005","volume":"191","author":"ZW Lai","year":"2013","unstructured":"Lai, Z. W. et al. Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus. J. Immunol. 191, 2236\u20132246 (2013).","journal-title":"J. Immunol."},{"key":"1267_CR138","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1002\/art.39720","volume":"68","author":"P Coit","year":"2016","unstructured":"Coit, P. et al. Epigenetic reprogramming in naive CD4+ T cells favoring T cell activation and non-Th1 effector T cell immune response as an early event in lupus flares. Arthritis Rheumatol. 68, 2200\u20132209 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"1267_CR139","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3389\/fimmu.2018.01364","volume":"9","author":"T Komai","year":"2018","unstructured":"Komai, T. et al. Transforming growth factor-\u03b2 and interleukin-10 synergistically regulate humoral immunity via modulating metabolic signals. Front. Immunol. 9, 1364 (2018).","journal-title":"Front. Immunol."},{"key":"1267_CR140","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1177\/09612033221119455","volume":"31","author":"M Li","year":"2022","unstructured":"Li, M. et al. Elevated apoptosis and abnormal apoptosis signaling of regulatory T cells in patients with systemic lupus erythematosus. Lupus 31, 1441\u20131455 (2022).","journal-title":"Lupus"},{"key":"1267_CR141","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4049\/jimmunol.1400931","volume":"193","author":"G Amarilyo","year":"2014","unstructured":"Amarilyo, G., Lourenco, E. V., Shi, F. D. & La Cava, A. IL-17 promotes murine lupus. J. Immunol. 193, 540\u2013543 (2014).","journal-title":"J. Immunol."},{"key":"1267_CR142","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","volume":"11","author":"J Shan","year":"2020","unstructured":"Shan, J., Jin, H. & Xu, Y. T cell metabolism: a new perspective on Th17\/Treg cell imbalance in systemic lupus erythematosus. Front. Immunol. 11, 1027 (2020).","journal-title":"Front. Immunol."},{"key":"1267_CR143","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.4049\/jimmunol.1602144","volume":"199","author":"Y Chen","year":"2017","unstructured":"Chen, Y. et al. IFN-\u03b3-expressing Th17 cells are required for development of severe ocular surface autoimmunity. J. Immunol. 199, 1163\u20131169 (2017).","journal-title":"J. Immunol."},{"key":"1267_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.593103","volume":"11","author":"S Iwata","year":"2020","unstructured":"Iwata, S. et al. Enhanced fatty acid synthesis leads to subset imbalance and IFN-\u03b3 overproduction in T helper 1 cells. Front. Immunol. 11, 593103 (2020).","journal-title":"Front. Immunol."},{"key":"1267_CR145","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ymthe.2022.09.013","volume":"31","author":"M Li","year":"2023","unstructured":"Li, M. et al. NAMPT is a metabolic checkpoint of IFN\u03b3-producing CD4+ T cells in lupus nephritis. Mol. Ther. 31, 193\u2013210 (2023).","journal-title":"Mol. Ther."},{"key":"1267_CR146","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc9657","volume":"8","author":"M Scherlinger","year":"2022","unstructured":"Scherlinger, M. et al. Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity. Sci. Adv. 8, eadc9657 (2022).","journal-title":"Sci. Adv."},{"key":"1267_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103198","volume":"145","author":"M Lin","year":"2024","unstructured":"Lin, M. et al. Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice. J. Autoimmun. 145, 103198 (2024).","journal-title":"J. Autoimmun."},{"key":"1267_CR148","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.4049\/jimmunol.1302062","volume":"192","author":"A Caro-Maldonado","year":"2014","unstructured":"Caro-Maldonado, A. et al. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J. Immunol. 192, 3626\u20133636 (2014).","journal-title":"J. Immunol."},{"key":"1267_CR149","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.4049\/jimmunol.2100356","volume":"208","author":"S-C Choi","year":"2022","unstructured":"Choi, S.-C. et al. Pharmacologically inferred glycolysis and glutaminolysis requirement of B cells in lupus-prone mice. J. Immunol. 208, 2098\u20132108 (2022).","journal-title":"J. Immunol."},{"key":"1267_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44540-0","volume":"15","author":"W Chi","year":"2024","unstructured":"Chi, W. et al. MCT1-governed pyruvate metabolism is essential for antibody class-switch recombination through H3K27 acetylation. Nat. Commun. 15, 163 (2024).","journal-title":"Nat. Commun."},{"key":"1267_CR151","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41590-020-0598-4","volume":"21","author":"FJ Weisel","year":"2020","unstructured":"Weisel, F. J. et al. Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis. Nat. Immunol. 21, 331\u2013342 (2020).","journal-title":"Nat. Immunol."},{"key":"1267_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107487","volume":"26","author":"JJ Wilson","year":"2023","unstructured":"Wilson, J. J. et al. Glucose oxidation-dependent survival of activated B cells provides a putative novel therapeutic target for lupus treatment. iScience 26, 107487 (2023).","journal-title":"iScience"},{"key":"1267_CR153","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4049\/jimmunol.1601908","volume":"199","author":"M Torigoe","year":"2017","unstructured":"Torigoe, M. et al. Metabolic reprogramming commits differentiation of human CD27+IgD+ B cells to plasmablasts or CD27\u2212IgD\u2212 cells. J. Immunol. 199, 425\u2013434 (2017).","journal-title":"J. Immunol."},{"key":"1267_CR154","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1002\/art.39750","volume":"68","author":"F Delunardo","year":"2016","unstructured":"Delunardo, F. et al. Anti-GAPDH autoantibodies as a pathogenic determinant and potential biomarker of neuropsychiatric diseases. Arthritis Rheumatol. 68, 2708\u20132716 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"1267_CR155","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7430780","volume":"2019","author":"J Sun","year":"2019","unstructured":"Sun, J. et al. Anti-GAPDH autoantibody is associated with increased disease activity and intracranial pressure in systemic lupus erythematosus. J. Immunol. Res. 2019, 7430780 (2019).","journal-title":"J. Immunol. Res."},{"key":"1267_CR156","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1093\/rheumatology\/keab824","volume":"61","author":"MH Sumikawa","year":"2022","unstructured":"Sumikawa, M. H. et al. An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus. Rheumatology 61, 3049\u20133059 (2022).","journal-title":"Rheumatology"},{"key":"1267_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/srep43479","volume":"7","author":"H Hu","year":"2017","unstructured":"Hu, H. et al. A genetically encoded toolkit for tracking live-cell histidine dynamics in space and time. Sci. Rep. 7, 43479 (2017).","journal-title":"Sci. Rep."},{"key":"1267_CR158","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230774","volume":"221","author":"S Liu","year":"2024","unstructured":"Liu, S. et al. NADPH oxidase exerts a B cell-intrinsic contribution to lupus risk by modulating endosomal TLR signals. J. Exp. Med. 221, e20230774 (2024).","journal-title":"J. Exp. Med."},{"key":"1267_CR159","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3389\/fimmu.2019.01026","volume":"10","author":"Y Becker","year":"2019","unstructured":"Becker, Y. et al. Autoantibodies in systemic lupus erythematosus target mitochondrial RNA. Front. Immunol. 10, 1026 (2019).","journal-title":"Front. Immunol."},{"key":"1267_CR160","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1182\/blood-2011-01-331462","volume":"118","author":"AV Rubtsov","year":"2011","unstructured":"Rubtsov, A. V. et al. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity. Blood 118, 1305\u20131315 (2011).","journal-title":"Blood"},{"key":"1267_CR161","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1241531","volume":"14","author":"I Ramirez De Oleo","year":"2023","unstructured":"Ramirez De Oleo, I. et al. Phenotypic and functional characteristics of murine CD11c+ B cells which is suppressed by metformin. Front. Immunol. 14, 1241531 (2023).","journal-title":"Front. Immunol."},{"key":"1267_CR162","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/art.42433","volume":"75","author":"X Han","year":"2023","unstructured":"Han, X. et al. Amelioration of autoimmunity in a lupus mouse model by modulation of T-Bet-promoted energy metabolism in pathogenic age\/autoimmune-associated B cells. Arthritis Rheumatol. 75, 1203\u20131215 (2023).","journal-title":"Arthritis Rheumatol."},{"key":"1267_CR163","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17179-4","volume":"11","author":"JA Bibby","year":"2020","unstructured":"Bibby, J. A. et al. Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate. Nat. Commun. 11, 3412 (2020).","journal-title":"Nat. Commun."},{"key":"1267_CR164","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41392-022-00948-6","volume":"7","author":"XY Wang","year":"2022","unstructured":"Wang, X. Y. et al. c-Myc-driven glycolysis polarizes functional regulatory B cells that trigger pathogenic inflammatory responses. Signal. Transduct. Target. Ther. 7, 105 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1267_CR165","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4049\/jimmunol.1801651","volume":"203","author":"AA Titov","year":"2019","unstructured":"Titov, A. A., Baker, H. V., Brusko, T. M., Sobel, E. S. & Morel, L. Metformin inhibits the type 1 IFN response in human CD4+ T cells. J. Immunol. 203, 338\u2013348 (2019).","journal-title":"J. Immunol."},{"key":"1267_CR166","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1002\/art.39296","volume":"67","author":"H Wang","year":"2015","unstructured":"Wang, H., Li, T., Chen, S., Gu, Y. & Ye, S. Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin. Arthritis Rheumatol. 67, 3190\u20133200 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"1267_CR167","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000611","volume":"9","author":"XC Chen","year":"2022","unstructured":"Chen, X. C. et al. Metformin improves renal injury of MRL\/lpr lupus-prone mice via the AMPK\/STAT3 pathway. Lupus Sci. Med. 9, e000611 (2022).","journal-title":"Lupus Sci. Med."},{"key":"1267_CR168","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.143245","volume":"6","author":"CS Wilson","year":"2021","unstructured":"Wilson, C. S. et al. Metabolic preconditioning in CD4+ T cells restores inducible immune tolerance in lupus-prone mice. JCI Insight 6, e143245 (2021).","journal-title":"JCI Insight"},{"key":"1267_CR169","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06686-0","volume":"9","author":"SC Choi","year":"2018","unstructured":"Choi, S. C. et al. Inhibition of glucose metabolism selectively targets autoreactive follicular helper T cells. Nat. Commun. 9, 4369 (2018).","journal-title":"Nat. Commun."},{"key":"1267_CR170","doi-asserted-by":"publisher","first-page":"15160","DOI":"10.1073\/pnas.2000943117","volume":"117","author":"C Jing","year":"2020","unstructured":"Jing, C. et al. Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis. Proc. Natl Acad. Sci. USA 117, 15160\u201315171 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1267_CR171","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2020-000429","volume":"7","author":"F Sun","year":"2020","unstructured":"Sun, F. et al. Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials. Lupus Sci. Med. 7, e000429 (2020).","journal-title":"Lupus Sci. Med."},{"key":"1267_CR172","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1016\/S2665-9913(20)30004-7","volume":"2","author":"F Sun","year":"2020","unstructured":"Sun, F. et al. Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Rheumatol. 2, e210\u2013e216 (2020).","journal-title":"Lancet Rheumatol."},{"key":"1267_CR173","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4049\/immunohorizons.2000033","volume":"4","author":"C Cornaby","year":"2020","unstructured":"Cornaby, C. et al. Efficacy of the combination of metformin and CTLA4Ig in the (NZB\u00a0\u00d7\u00a0NZW)F1 mouse model of lupus nephritis. Immunohorizons 4, 319\u2013331 (2020).","journal-title":"Immunohorizons"},{"key":"1267_CR174","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1002\/art.39791","volume":"68","author":"Z Oaks","year":"2016","unstructured":"Oaks, Z. et al. Mitochondrial dysfunction in the liver and antiphospholipid antibody production precede disease onset and respond to rapamycin in lupus-prone mice. Arthritis Rheumatol. 68, 2728\u20132739 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"1267_CR175","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","volume":"391","author":"ZW Lai","year":"2018","unstructured":"Lai, Z. W. et al. Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial. Lancet 391, 1186\u20131196 (2018).","journal-title":"Lancet"},{"key":"1267_CR176","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12631","volume":"31","author":"M Herold","year":"2018","unstructured":"Herold, M., Richmond, N. A., Montuno, M. A., Wesson, S. K. & Motaparthi, K. Rapamycin for refractory discoid lupus erythematosus. Dermatol. Ther. 31, e12631 (2018).","journal-title":"Dermatol. Ther."},{"key":"1267_CR177","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/art.40380","volume":"70","author":"H Kato","year":"2018","unstructured":"Kato, H. & Perl, A. Blockade of Treg cell differentiation and function by the interleukin-21-mechanistic target of rapamycin axis via suppression of autophagy in patients with systemic lupus erythematosus. Arthritis Rheumatol. 70, 427\u2013438 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"1267_CR178","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1002\/art.22085","volume":"54","author":"D Fernandez","year":"2006","unstructured":"Fernandez, D., Bonilla, E., Mirza, N., Niland, B. & Perl, A. Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. Arthritis Rheum. 54, 2983\u20132988 (2006).","journal-title":"Arthritis Rheum."},{"key":"1267_CR179","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3390\/biom13030401","volume":"13","author":"A Dioszegi","year":"2023","unstructured":"Dioszegi, A. et al. Role of altered metabolism of triglyceride-rich lipoprotein particles in the development of vascular dysfunction in systemic lupus erythematosus. Biomolecules 13, 401 (2023).","journal-title":"Biomolecules"},{"key":"1267_CR180","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1136\/annrheumdis-2013-204351","volume":"74","author":"P Ruiz-Limon","year":"2015","unstructured":"Ruiz-Limon, P. et al. Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment. Ann. Rheum. Dis. 74, 1450\u20131458 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"1267_CR181","doi-asserted-by":"publisher","first-page":"7416","DOI":"10.4049\/jimmunol.177.10.7416","volume":"177","author":"EC Jury","year":"2006","unstructured":"Jury, E. C., Isenberg, D. A., Mauri, C. & Ehrenstein, M. R. Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus. J. Immunol. 177, 7416\u20137422 (2006).","journal-title":"J. Immunol."},{"key":"1267_CR182","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.4049\/jimmunol.181.6.4019","volume":"181","author":"GM Deng","year":"2008","unstructured":"Deng, G. M. & Tsokos, G. C. Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation. J. Immunol. 181, 4019\u20134026 (2008).","journal-title":"J. Immunol."},{"key":"1267_CR183","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1172\/JCI69571","volume":"124","author":"G McDonald","year":"2014","unstructured":"McDonald, G. et al. Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients. J. Clin. Invest. 124, 712\u2013724 (2014).","journal-title":"J. Clin. Invest."},{"key":"1267_CR184","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1038\/s42255-024-01149-x","volume":"6","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Farnesyl pyrophosphate potentiates dendritic cell migration in autoimmunity through mitochondrial remodelling. Nat. Metab. 6, 2118\u20132137 (2024).","journal-title":"Nat. Metab."},{"key":"1267_CR185","doi-asserted-by":"publisher","first-page":"705","DOI":"10.14423\/SMJ.0000000000000561","volume":"109","author":"RT Artola","year":"2016","unstructured":"Artola, R. T., Mihos, C. G. & Santana, O. Effects of statin therapy in patients with systemic lupus erythematosus. South. Med. J. 109, 705\u2013711 (2016).","journal-title":"South. Med. J."},{"key":"1267_CR186","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.autrev.2015.12.007","volume":"15","author":"A Sahebkar","year":"2016","unstructured":"Sahebkar, A., Rathouska, J., Derosa, G., Maffioli, P. & Nachtigal, P. Statin impact on disease activity and C-reactive protein concentrations in systemic lupus erythematosus patients: a systematic review and meta-analysis of controlled trials. Autoimmun. Rev. 15, 344\u2013353 (2016).","journal-title":"Autoimmun. Rev."},{"key":"1267_CR187","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.immuni.2016.04.006","volume":"44","author":"A Haghikia","year":"2016","unstructured":"Haghikia, A. et al. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity 44, 951\u2013953 (2016).","journal-title":"Immunity"},{"key":"1267_CR188","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08711-2","volume":"10","author":"M Luu","year":"2019","unstructured":"Luu, M. et al. The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes. Nat. Commun. 10, 760 (2019).","journal-title":"Nat. Commun."},{"key":"1267_CR189","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.3389\/fimmu.2020.01796","volume":"11","author":"KA Wierenga","year":"2020","unstructured":"Wierenga, K. A. et al. Requisite omega-3 HUFA biomarker thresholds for preventing murine lupus flaring. Front. Immunol. 11, 1796 (2020).","journal-title":"Front. Immunol."},{"key":"1267_CR190","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.650856","volume":"12","author":"A Kobayashi","year":"2021","unstructured":"Kobayashi, A. et al. Dietary supplementation with eicosapentaenoic acid inhibits plasma cell differentiation and attenuates lupus autoimmunity. Front. Immunol. 12, 650856 (2021).","journal-title":"Front. Immunol."},{"key":"1267_CR191","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/08923973.2019.1616754","volume":"41","author":"CC Qiu","year":"2019","unstructured":"Qiu, C. C., Atencio, A. E. & Gallucci, S. Inhibition of fatty acid metabolism by etomoxir or TOFA suppresses murine dendritic cell activation without affecting viability. Immunopharmacol. Immunotoxicol. 41, 361\u2013369 (2019).","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"1267_CR192","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12882-022-02870-z","volume":"23","author":"X Li","year":"2022","unstructured":"Li, X. et al. 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-\u03baB and MAPK signalling pathways in MRL\/lpr mice. BMC Nephrol. 23, 243 (2022).","journal-title":"BMC Nephrol."},{"key":"1267_CR193","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.4049\/jimmunol.179.3.1634","volume":"179","author":"S Chen","year":"2007","unstructured":"Chen, S. et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol. 179, 1634\u20131647 (2007).","journal-title":"J. Immunol."},{"key":"1267_CR194","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.clim.2013.07.002","volume":"149","author":"W Zhao","year":"2013","unstructured":"Zhao, W. et al. The peroxisome-proliferator activated receptor-\u03b3 agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosus. Clin. Immunol. 149, 119\u2013132 (2013).","journal-title":"Clin. Immunol."},{"key":"1267_CR195","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1089\/ars.2013.5702","volume":"21","author":"E Doherty","year":"2014","unstructured":"Doherty, E., Oaks, Z. & Perl, A. Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus. Antioxid. Redox Signal. 21, 56\u201365 (2014).","journal-title":"Antioxid. Redox Signal."},{"key":"1267_CR196","doi-asserted-by":"publisher","DOI":"10.1097\/IN9.0000000000000010","volume":"4","author":"S Nasr","year":"2022","unstructured":"Nasr, S. & Perl, A. Principles behind SLE treatment with N-acetylcysteine. Immunometabolism 4, e00010 (2022).","journal-title":"Immunometabolism"},{"key":"1267_CR197","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2020-000387","volume":"7","author":"KA Fortner","year":"2020","unstructured":"Fortner, K. A. et al. Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice. Lupus Sci. Med. 7, e000387 (2020).","journal-title":"Lupus Sci. Med."},{"key":"1267_CR198","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/art.41128","volume":"72","author":"LP Blanco","year":"2020","unstructured":"Blanco, L. P. et al. Improved mitochondrial metabolism and reduced inflammation following attenuation of murine lupus with coenzyme Q10 analog idebenone. Arthritis Rheumatol. 72, 454\u2013464 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"1267_CR199","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/art.42284","volume":"74","author":"LP Blanco","year":"2022","unstructured":"Blanco, L. P. et al. Modulation of the itaconate pathway attenuates murine lupus. Arthritis Rheumatol. 74, 1971\u20131983 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"1267_CR200","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature25986","volume":"556","author":"EL Mills","year":"2018","unstructured":"Mills, E. L. et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556, 113\u2013117 (2018).","journal-title":"Nature"},{"key":"1267_CR201","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4049\/jimmunol.2400241","volume":"213","author":"E Patino-Martinez","year":"2024","unstructured":"Patino-Martinez, E. et al. The aconitate decarboxylase 1\/Itaconate pathway modulates immune dysregulation and associates with cardiovascular disease markers and disease activity in systemic lupus erythematosus. J. Immunol. 213, 419\u2013434 (2024).","journal-title":"J. Immunol."},{"key":"1267_CR202","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41586-024-07282-7","volume":"629","author":"JP Auger","year":"2024","unstructured":"Auger, J. P. et al. Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids. Nature 629, 184\u2013192 (2024).","journal-title":"Nature"},{"key":"1267_CR203","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/j.jaad.2013.12.004","volume":"71","author":"A Tsianakas","year":"2014","unstructured":"Tsianakas, A. et al. Successful treatment of discoid lupus erythematosus with fumaric acid esters. J. Am. Acad. Dermatol. 71, e15\u2013e17 (2014).","journal-title":"J. Am. Acad. Dermatol."},{"key":"1267_CR204","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/bjd.14698","volume":"176","author":"AM Saracino","year":"2017","unstructured":"Saracino, A. M. & Orteu, C. H. Severe recalcitrant cutaneous manifestations in systemic lupus erythematosus successfully treated with fumaric acid esters. Br. J. Dermatol. 176, 472\u2013480 (2017).","journal-title":"Br. J. Dermatol."},{"key":"1267_CR205","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4049\/jimmunol.2200848","volume":"211","author":"C Diskin","year":"2023","unstructured":"Diskin, C., Day, E. A., Henry, O. C., Toller-Kawahisa, J. E. & O\u2019Neill, L. A. J. 4-octyl itaconate and dimethyl fumarate induce secretion of the anti-inflammatory protein annexin A1 via NRF2. J. Immunol. 211, 1032\u20131041 (2023).","journal-title":"J. Immunol."},{"key":"1267_CR206","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.123.066039","volume":"148","author":"MA Walker","year":"2023","unstructured":"Walker, M. A. et al. Raising NAD+ level stimulates short-chain dehydrogenase\/reductase proteins to alleviate heart failure independent of mitochondrial protein deacetylation. Circulation 148, 2038\u20132057 (2023).","journal-title":"Circulation"},{"key":"1267_CR207","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139828","volume":"132","author":"J Wu","year":"2022","unstructured":"Wu, J. et al. Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes. J. Clin. Invest. 132, e139828 (2022).","journal-title":"J. Clin. Invest."},{"key":"1267_CR208","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06032923 (2024)."},{"key":"1267_CR209","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LA O\u2019Neill","year":"2016","unstructured":"O\u2019Neill, L. A., Kishton, R. J. & Rathmell, J. A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16, 553\u2013565 (2016).","journal-title":"Nat. Rev. Immunol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01267-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01267-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01267-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T08:02:47Z","timestamp":1750924967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01267-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":209,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1267"],"URL":"https:\/\/doi.org\/10.1038\/s41584-025-01267-0","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"7 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}